Novel transcript antisense to actin gamma 1 (ENSG00000289182)

This gene encodes a **natural antisense transcript complementary to the ACTG1 (actin gamma 1) gene**. Antisense transcripts like this are non-coding RNAs, often classified as long non-coding RNAs, that overlap with the coding (sense) transcript but are transcribed from the opposite DNA strand[1][3]. Such RNAs can regulate their corresponding sense gene (here, ACTG1) by multiple mechanisms, including interfering with sense transcript production, modulating RNA processing, promoting RNA degradation, or influencing chromatin state and epigenetic marks. Generally, the functional consequence is to fine-tune or repress the expression of the associated protein-coding gene[3][5]. There is currently no direct evidence that this particular antisense transcript is involved in disease, acts as a drug target, or serves as a biomarker. It is not considered a therapeutic target in the conventional sense (such as a receptor, enzyme, or transporter)[1][3][5].

Other names

Novel transcript, antisense to ACTG1

Transcriptional interference\n- RNA masking\n- Double-stranded RNA (dsRNA)-dependent mechanisms (including possibly RNA interference)\n- Chromatin remodeling[3][5]